Infectious Disease CDMOs

Sussex Research Laboratories

Canada

Sussex Research Laboratories Inc. is a Canadian CRO and CDMO specializing in glycoscience -- the study and application of carbohydrates (glycans) in drug discovery and development. The company provides custom carbohydrate synthesis, GalNAc-based drug delivery strategies, glycoconjugate development, and scale-up services for pharmaceutical and biotech clients, with over 25 years of industry experience and 1,000+ clients globally.

Synergene Active Ingredients Private Limited

India

Synergene Active Ingredients is a fast-growing Indian API manufacturer incorporated in 2006, with 40 years of industrial experience and 800+ employees. The company manufactures 30+ APIs serving 300+ customers in 50+ countries. Synergene operates four manufacturing units in Hyderabad and Visakhapatnam with combined production capacity of 800+ KL (plus 700 KL under installation). The company has CEPs from EDQM, US DMFs, Japanese DMFs, ANVISA CBPF, and WHO GMP certifications. Synergene also produces specialty chemicals for skincare, sun care, and haircare applications.

TITAN PHARMAPLUS PVT. LTD

India

Titan Pharmaplus Pvt. Ltd. is an Indian pharmaceutical API manufacturer and CDMO committed to innovation, quality, and sustainability. The company produces a wide range of small molecule APIs including Apixaban, Dapagliflozin, Acyclovir, Dexlansoprazole, and controlled substances, with state-of-the-art cGMP facilities and advanced chemical synthesis capabilities including high-pressure hydrogenation, Grignard reactions, and asymmetric oxidation.

Touchlight

United Kingdom

Touchlight is a UK-based CDMO pioneering enzymatic GMP DNA production using its proprietary cell-free dbDNA technology. Founded in 2007 and based in London, the company manufactures high-purity DNA for genetic medicines across applications including mRNA, AAV viral vectors, lentiviral vectors, gene editing, DNA vaccines, and non-viral gene therapy. Touchlight holds a world-first MHRA GMP certification for synthetic DNA manufacturing and has 9 programs in the clinic using dbDNA.

Trifarma S.p.A.

Italy

Trifarma S.p.A. is an international and independent Italian group dedicated to developing, manufacturing, and supplying high-quality Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. The company has R&D laboratories for synthetic organic chemistry process development at lab and pilot scale, with rapid lab-to-industrial scale development. API portfolio covers cardiovascular, anti-infective, nervous system, dermatological/ophthalmic, steroids, and musculoskeletal categories.

Unilab Chemicals & Pharmaceuticals Pvt Ltd

India

Unilab Chemicals & Pharmaceuticals Pvt Ltd is an Indian manufacturer of Active Pharmaceutical Ingredients (APIs), bulk drugs, and finished dosage forms, established in 1978 near Mumbai. Their product portfolio focuses heavily on antiseptic and disinfectant APIs and formulations including Chlorhexidine Gluconate, Povidone Iodine, Cetrimide, Benzalkonium Chloride, and related topical/liquid formulations. They also manufacture APIs like Guaifenesin, Phenothiazine, and other pharmaceutical chemicals.

Vector BioMed

United States

Vector BioMed is a U.S.-based public benefit corporation and CDMO specializing in lentiviral vector design and manufacturing for cell and gene therapies. Launched following $15M in funding, the company provides essential lentiviral vector capabilities using their proprietary LENTIVERSE platform. They produce high-titer (>10^9 TU/mL) lentiviral vectors using a serum-free, chemically-defined process. Key differentiators include algorithm-optimized vector design, rapid turnaround (months from onboarding to GMP batch release), modular pre-validated systems to reduce costs and avoid royalty-based constraints, and a focus on making advanced therapies accessible in lower-resource settings. They partner with CIRM (California Institute for Regenerative Medicine) on lentiviral vector manufacture.

Advaxia Biologics is a CDMO near Rome, Italy, specializing in adenovirus vaccine development and cGMP manufacturing. With over 10 years of biologics expertise and a 100% batch approval rate, Advaxia provides fully integrated services from expression systems and process development to analytical development and GMP manufacturing, and is EMA, FDA, and AIFA compliant.

Anhui Biochem Pharmaceutical (ABUP) is a Chinese pharmaceutical company manufacturing APIs, intermediates, and finished dosage forms, with a focus on antiviral drugs (AIDS and hepatitis) and Parkinson's disease medications. They also offer customized processing (contract manufacturing) services.

Bacthera was a specialized CDMO focused on live biotherapeutic products (LBPs) and microbiome-based therapeutics, operating as a joint venture that originated from Lonza and Chr. Hansen. The company provided development and cGMP manufacturing services across the live biotherapeutics value chain, from drug substance production through drug product manufacturing. Bacthera collaborated with Seres Therapeutics for commercial manufacturing of SER-109 (a treatment for recurrent C. difficile infection), acquired a cGMP site in Leon, Spain, and received regulatory approvals from Swissmedic and the Danish Medicines Agency. However, Bacthera ceased its CDMO operations by September 2025, with its equipment subsequently acquired by EXPERT'Biome (Lallemand's CDMO division). Note: this company has closed its CDMO operations.

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.

Catalysis S.L.

Spain

Catalysis S.L. is a Spanish nutraceutical laboratory focused on the development of functional nutritional supplements and dermocosmetics that help improve health. The company is not a pharmaceutical contract manufacturer but rather develops and markets its own nutraceutical product lines.

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

Cobra Biologics is an international CDMO specializing in plasmid DNA, viral vectors, and aseptic pharmaceutical manufacturing, now part of Charles River Laboratories following the acquisition of Cognate BioServices. The company operates facilities in the UK and Sweden (Matfors), providing clinical and commercial-scale manufacturing of gene therapy products, with expanded viral vector suite capabilities and collaborations in COVID-19 vaccine manufacturing.

Deretil S.A.

Spain

Deretil is a Spanish company with over 50 years of experience in pharmaceutical raw material manufacturing, operating as a Contract Manufacturing Organisation. They specialize in the development and manufacture of side chains for beta-lactam antibiotics, including Amoxicillin and related intermediates, integrating production from raw material phases through final API products.

Eletis Medica

Lithuania

UAB Eletis Medica is a Lithuanian pharmaceutical company that manufactures and markets antibacterial preparations including products containing meropenem, cefazolin, ceftriaxone, and other anti-infective agents. No website is accessible and available search results show the company primarily as a pharmaceutical product marketer on CPHI, not as a contract manufacturer or CDMO.

FarmaTek

Turkey

FarmaTek (Farmatek Ilac San ve Tic A.S.) is a Turkish pharmaceutical company founded in 1991 that transitioned from drug importing to manufacturing, incorporating a hybrid business model including CDMO services. The company operates a GMP-approved production facility in Kirklareli Organized Industrial Zone (approved 2017) and received EU GMP certification in 2021.

Fujirebio

Belgium

Fujirebio is a global in vitro diagnostics (IVD) company with over 50 years of expertise in biomarker innovation, offering CDMO services for diagnostic products. The company provides contract development and manufacturing for diagnostic partners, including reagent development, manufacturing, and clinical and regulatory services. Fujirebio is particularly known for its FDA-cleared Alzheimer's disease blood-based biomarkers on its Lumipulse platform.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.

GC Biopharma

South Korea

GC Biopharma is a South Korean biopharmaceutical company specializing in vaccines, plasma-derived therapies, and biologics. The company provides Vial and Pre-Filled Syringe (PFS) Fill & Finish CMO services and drug product (DP) manufacturing as CDMO services. GC Biopharma has established an mRNA production facility at its Hwasun plant and operates multiple manufacturing sites including Ochang, Hwasun, and Eumseong plants.

GreenLight Clinical

Australia

GreenLight Clinical is an Australian full-service Contract Research Organisation (CRO) specializing in ophthalmology, oncology, rare diseases, and gene and cell therapy clinical trials. The company provides clinical monitoring, project management, data management, regulatory affairs, and site management services for biotech and pharmaceutical sponsors.

Huazhong Pharmaceutical Co., Ltd. (HPC) is a Chinese pharmaceutical company established in 1995, manufacturing APIs, intermediates, and finished dosage forms including tablets. The company has GMP manufacturing sites with capabilities in both biological transformations and chemical synthesis, producing products such as albendazole, isoniazid, paracetamol, and nifedipine tablets.

ICON plc

Australia

ICON plc is a leading global clinical research organization (CRO) providing end-to-end drug development services. The company offers bioanalytical laboratory services, specialty laboratory solutions, clinical supplies management, regulatory consulting, and early clinical development across all phases of drug development. ICON operates globally with GMP-trained experts.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Northeast Pharmaceutical Group (NEPG) is a large-scale comprehensive pharmaceutical enterprise in Shenyang, China, under Fangda Group. The company operates three major business segments: chemical synthetic API and bio-fermentation API, western medicinal preparations and micro-ecological preparations, and medical business distribution. NEPG is China's first Vitamin C producer and the inventor of the two-step fermentation technology for VC production, with the world's largest Piracetam production capacity.

Novotech

Australia

Novotech is a global full-service clinical research organization (CRO) headquartered in Australia, specializing as a biotech partner across all clinical trial phases. The company operates extensively in Asia-Pacific and globally, providing clinical trial management, regulatory advisory, and scientific consulting services for biotech and small to mid-sized pharma companies.

Pace Life Sciences is a division of Pace Analytical Services LLC, operating as a full-service CDMO/CRO network across the United States. The company supports drug development across the entire lifecycle from preclinical research through commercialization, specializing in small molecules, biologics (proteins, peptides, monoclonal antibodies, ADCs), nucleic acids (oligonucleotides, mRNA, plasmid DNA), and gene therapies. Recognized by PharmaSource as a Top CDMO in the United States. Operates 9+ strategically located sites including a sterile fill-finish Center of Excellence in Salem, NH.

Parexel International (MA) Corporation

Argentina

Parexel is a global contract research organization (CRO) providing clinical trial management, regulatory consulting, and biopharmaceutical development services. With over 24,000 professionals and 50+ clinical sites across five continents, the company offers Phase I-IV clinical trial services, CMC regulatory strategy, and real-world evidence generation. Parexel is primarily a CRO, not a drug manufacturer.

PharmIdea is a Latvian CDMO located in Olaine, Latvia, specializing in sterile drug development, commercial production, and worldwide supply of pharmaceutical products. The company focuses on sterile drugs in vials, offering contract manufacturing services including product development. PharmIdea has completed CTDs for out-licensing and provides contract manufacturing of sterile injectables such as Levosimendan concentrate for solution for infusion (small batch), Caspofungin, and Carbetocin. The company has partnered with Lidds for manufacturing NZ-TLR9 formulation against solid tumors.

PRIMA LAB SA

Switzerland

PRIMA LAB SA is a Swiss company (part of the Sentinel group) that manufactures rapid diagnostic test kits including pregnancy tests, HIV self-tests, Strep A tests, and other lateral flow rapid tests for both self and professional use. Listed on CPHI Online with company types including CMO/CDMO, but their actual products are diagnostic test kits, not drug manufacturing. They are a medical diagnostics/IVD manufacturer, not a pharmaceutical CDMO.

SEDICO Pharmaceutical Company is an Egypt-based pharmaceutical manufacturer and API producer, providing contract manufacturing (CMO/CDMO) services. The company manufactures a broad range of pharmaceutical products including oral solids, injectables, and various dosage forms. SEDICO has recently entered oncology drug production through a partnership with Sandoz Global to localize oncology pharmaceutical products in Egypt.

ST Pharm is a South Korean global API CDMO company founded in 1983, specializing in small molecule APIs, oligonucleotide therapeutics (ASO, siRNA, aptamers), and mRNA-LNP manufacturing. The company operates cGMP manufacturing facilities in South Korea and has a CRO subsidiary (AnaPath) in Switzerland and Spain for preclinical pathology services.

Division of Terumo Corporation (TSE:4543), a global healthcare technology leader since 1921 with 30,000+ employees. Provides sterile injectable contract development and manufacturing (CDMO) services from combination device design and formulation development to commercial manufacturing. Offers a portfolio of injection, infusion, and primary packaging solutions including PLAJEX polymer pre-fillable syringes, Immucise intradermal injection systems, hypodermic needles, and Surflo winged infusion sets. Recently expanded CDMO services outside Japan for global market and is doubling capacity.

Duplicate entry for VGXI Inc (see companyId 58cac364). Same company -- leading plasmid DNA CDMO in Texas. Same website URL (vgxii.com). Same capabilities, facilities, and services.

Vibalogics is a specialized global CDMO for virotherapy manufacturing, now operating as Recipharm Advanced Bio after acquisition by Recipharm AB. The company offers process and analytical development, GMP manufacturing of viral vectors, oncolytic viruses, and advanced therapies. Capabilities include xRNA therapies, viral vectors (AAV, lentivirus), microbial/live biotherapeutic products, recombinant proteins, plasmid DNA, and lipid nanoparticles. Major $50M expansion of Cuxhaven facility (500L manufacturing line) completed. 118,000 sq ft GMP facility in Massachusetts (US) also completed.

Zhejiang Davi Pharmaceutical Co., Ltd., established in 2004, is an exclusively foreign-owned high-tech manufacturer of active pharmaceutical ingredients and intermediates located in Huzhou City, Zhejiang, China. With a total investment of $8M USD and 35,000 m2 floor space, they operate FDA and COS-required GMP workshops. They specialize in folate-related APIs: Methotrexate, Methotrexate Sodium, Calcium Folinate (Leucovorin Calcium), Calcium Levofolinate, and L-5-Methyltetrahydrofolate Calcium. The company is FDA-registered with 3 FEI numbers, has 8 FDA inspections (2 NAI, 6 VAI, 0 OAI), 1 Class II recall, 4 FDA-approved products (tablet, extended-release tablet), and participates at CPHI events globally. They undertake OEM orders for intermediates. Classified as API manufacturer rather than CDMO because they primarily manufacture their own specialty APIs; contract services appear limited to OEM intermediate orders.

Zhejiang Hisoar Pharmaceutical Co., Ltd. (stock code 002099, Shenzhen Exchange), founded in 1966 and headquartered in Taizhou, Zhejiang, China, is a diversified pharmaceutical and chemical company with ~3,000 employees and 426 R&D personnel. Their pharmaceutical division produces specialty APIs, intermediates, formulations, and fine chemicals -- specifically antibiotics (penem/carbapenem series, clindamycin series), cardiovascular agents, and anti-diabetic APIs. Over 70% of products are exported. They also have a major dye/pigment business segment (~70% global market share in Reactive Blue KN-R). The company has 3 FDA-registered FEI numbers for API manufacture, 7 FDA inspections (4 NAI, 3 VAI, 0 OAI), 2 FDA-approved products (capsule, tablet), 40+ invention patents, and partnerships with Boehringer Ingelheim, Merck, Sanofi, Novartis, GSK, and others. Classified as API manufacturer because the core pharma business is own-brand API and intermediate production with limited CDMO positioning, though PharmaSource lists them under CMO/CDMO.

Acebright Group (Shanghai Acebright Pharmaceuticals) is a Chinese pharmaceutical company providing CDMO services through NMPA, FDA, EMA, and WHO-approved sites. They specialize in API manufacturing with over 20 years of technology development, and have a joint venture with Cipla for respiratory products in China.

Chongqing Carelife Pharmaceutical Co., Ltd. (Kailin Pharmaceutical) is a Chinese pharmaceutical company offering CDMO services for API manufacturing. The company has 2 FDA-registered facilities with 10 FDA inspections on record, producing APIs including clindamycin and amenamevir for domestic and international markets.

etherna (including its manufacturing arm etherna manufacturing) is a Belgian mRNA technology platform company that designs and manufactures research-grade and GMP-grade mRNA. The company provides custom drug delivery and mRNA manufacturing services, supporting partners from concept through clinical development.

FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth Biotechnologies) is a global biologics CDMO operating 10 facilities across the US, UK, Denmark, and Japan with over 4,800 employees. The company provides end-to-end cGMP manufacturing services for biologics, advanced therapies, and vaccines, from preclinical through commercialization, with $8.6 billion invested in recent years and 20+ commercial licenses.

Hangzhou FST Pharmaceutical Co., Ltd., established in 2001, is a Chinese national high-tech enterprise primarily engaged in the R&D and production of APIs and pharmaceutical intermediates. The company focuses on antitumor (tinib series), cardiovascular, antihistamine, antipsychotic, and antiviral product lines, selling to South Korea, the Middle East, Europe, the United States and other regions.

Hubei Yitai Pharmaceutical Co., Ltd. is a specialized manufacturer of chemical APIs and food additives based in Hubei, China. The company is listed among top CMOs for small molecule API manufacturing with containment capabilities and participates in major pharma exhibitions such as CPhI China.

KBI Biopharma

Switzerland

KBI Biopharma is a global biologics CDMO (part of JSR Life Sciences) providing mammalian and microbial-based biopharmaceutical development and manufacturing services. Offers cell line development (SUREtechnology Platform powered by Selexis for CHO, PUREplatform for E. coli), process development, analytical development, formulation development, characterization, clinical and commercial GMP manufacturing. FDA registered (FEI 3004638264) with ANALYSIS, API MANUFACTURE, and MANUFACTURE operations. Positioned as a 'next-generation CDMO' with standalone services portal for analytical testing.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.

MassBiologics, a division of UMass Chan Medical School, is a US-based biologics CDMO with over 100 years of history driving discoveries to products. The organization develops novel biologics for diseases of public health importance and offers CMO services including bulk drug manufacture of monoclonal antibodies, vectored therapeutics (gene therapy), and aseptic fill finish. The facility includes approximately 25,000 sq ft of cGMP manufacturing space with dedicated aseptic fill finish and bulk drug substance areas. FDA-registered with 3 FEI numbers. Produces the FDA-licensed Td vaccine and has partnerships for gene therapy manufacturing (SparingVision, PTC Therapeutics).

Newland Pharmaceutical is a Chinese company located in Changge City, Henan Province, founded in 2005. It is a globally important manufacturer of amoxicillin side-chain intermediates (L-PHPG Base, PTSA, L-PHPG Methyl Ester) and pharmaceutical intermediates. The company is a Henan Province 'Specialized, Refined, Differentiated, and Innovative' enterprise with core technology patents in 8 countries.

North China Pharmaceutical Group Corp. (NCPC) is one of China's largest pharmaceutical enterprises with multiple GMP manufacturing sites capable of both biological transformations and chemical synthesis. The company specializes in antibiotics, anti-allergy preparations, and antiviral products. NCPC has 3 FDA-registered FEI numbers and 7 FDA inspections (all VAI), indicating substantial but compliance-challenging export operations.